தொற்று நோய்கள் ப்ரோக்ராம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொற்று நோய்கள் ப்ரோக்ராம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொற்று நோய்கள் ப்ரோக்ராம் Today - Breaking & Trending Today

Rapid test kit for malaria delivers results in 30 minutes


Rapid test kit for malaria delivers results in 30 minutes
A team of scientists from
Nanyang Technological University, Singapore (NTU Singapore)
has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages.
According to the World Health Organisation (WHO), an estimated 229 million people suffered from malaria in 2019. The disease, transmitted by mosquitoes, caused the deaths of 409,000 people across 87 mainly developing countries.
Efforts to treat and control malaria in developing countries and rural areas are hindered by high cost and the lack of infrastructure. Rapid diagnostic tests (RDTs) for malaria are unable to detect infections during the early stages of the disease, but can give false positive or negative results. They also do not determine the severity of t ....

Liu Quan , Laurent Renia , Emily Henderson , Lee Kong Chian School Of Medicinewho , School Of Chemical , Nanyang Technological University , Infectious Diseases Programme , World Health Organisation , Study Lead , Associate Professor , Biomedical Engineering , Professor Laurent Renia , Kong Chian School , லியூ குவான் , எமிலி ஹென்டர்சன் , பள்ளி ஆஃப் இரசாயன , தொற்று நோய்கள் ப்ரோக்ராம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , படிப்பு வழி நடத்து , இணை ப்ரொஃபெஸர் , உயிர் மருத்துவ பொறியியல் , காங் சியான் பள்ளி ,

Researchers design armored immune cells to attack recurring cancer in liver transplant patients


Researchers design armored immune cells to attack recurring cancer in liver transplant patients
Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant drugs patients take to avoid organ rejection. The findings were published in the journal
Hepatology.
Hepatocellular carcinoma is the most common type of primary liver cancer and the sixth most common cancer worldwide. It often develops in people with chronic liver disease following hepatitis B infection.
A common treatment for hepatocellular carcinoma is to completely remove the liver and replace it with a healthy one from a donor. However, hepatitis B-related hepatocellular carcinoma can recur in some patients following transplantation. To kill the cancer, doctors can inject immune cells, called T cells, which are specially designed to target hepatitis ....

Patrick Casey , Antonio Bertoletti , Emily Henderson , Dean For Research , Infectious Diseases Programme , Professor Antonio Bertoletti , Emerging Infectious Diseases , Prof Bertoletti , Senior Vice Dean , Hepatitis B , Hepatocellular Carcinoma , Liver Cancer , Liver Disease , Liver Transplant , Medical School , பேட்ரிக் வழக்கு , எமிலி ஹென்டர்சன் , டீன் க்கு ஆராய்ச்சி , தொற்று நோய்கள் ப்ரோக்ராம் , வளர்ந்து வருகிறது தொற்று நோய்கள் , மூத்தவர் துணை டீன் , கல்லீரல் புற்றுநோய் , கல்லீரல் நோய் , கல்லீரல் மாற்று , மருத்துவ பள்ளி ,

Singapore designs 'armoured' anti-cancer T cells against immunosuppressants


Singapore designs armoured anti-cancer T cells against immunosuppressants
19 January 2021 | News
New ‘armoured’ T cells attack cancer without being suppressed by drugs given to transplant patients to avoid organ rejection.
Photo Credit: Freepik
Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armoured immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant drugs patients take to avoid organ rejection. The findings were published in the journal
Hepatology.
Hepatocellular carcinoma is the most common type of primary liver cancer and the sixth most common cancer worldwide. It often develops in people with chronic liver disease following hepatitis B infection. ....

Patrick Casey , Antonio Bertoletti , Dean For Research , Infectious Diseases Programme , Professor Antonio Bertoletti , Emerging Infectious Diseases , Prof Bertoletti , Professor Patrick Casey , Senior Vice Dean , Anti Cancert Cells Against Immunosuppressants , பேட்ரிக் வழக்கு , டீன் க்கு ஆராய்ச்சி , தொற்று நோய்கள் ப்ரோக்ராம் , வளர்ந்து வருகிறது தொற்று நோய்கள் , ப்ரொஃபெஸர் பேட்ரிக் வழக்கு , மூத்தவர் துணை டீன் ,